certara evidence and access
Published 3 years ago • 193 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
2:16
join the certara team!
-
28:02
a look into market access radar (mar)
-
1:38
voices of certara featuring max vargas (part 1)
-
1:04:54
the rare disease drug dilemma: great value, high price, limited access?
-
46:42
the scary future of rare disease management
-
31:50
certara's better drug discovery and development process
-
55:22
secondary intelligence: evidence-based secondary pharmacology insights-originally presented at sps
-
44:12
quantitative systems pharmacology for drug discovery and development
-
50:32
an introduction to european market access
-
57:06
small molecules, biologics, and vaccines: three uniquely divergent roads to fda cmc approval
-
1:41:04
strategic evidence & value communication symposium
-
44:45
certara send webinar series session #1
-
0:39
market access radar
-
30:56
a drug development software and services overview with a focus on rsnlme and simcyp
-
9:31
certara talks - ascpt 2024
-
2:21
voices of certara featuring max vargas (part 2)
-
0:56
optimize the clinical and economic value of your assets
-
1:34
vyasa layar explainer
-
3:07
a look into market access radar (mar) - customer request & example (ad hoc research)
-
7:08
strengths and opportunities for htas and market access in europe through case studies.
-
5:46
clinical pharmacogenetics dataset